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Staphylococci that possess protein A, a bacterial receptor for the Fc Received for publication 20 October 1978 and in revised form 29 (2) (3) (4) (5) (6) (7) . Blood platelets are intimately involved in the mechanism of thrombosis (8) , and staphylococci are among the microorganisms known to interact with platelets (9) . The mode of human platelet interaction with staphylococci, however, remains obscure. Unlike gram-negative bacteria, which produce a complex lipopolysaccharide endotoxin able to activate platelets (10, 11) , pathogenic staphylococci possess a cell wall component termed protein A (12) . It is covalently bound to the cell wall of 40% of the isolates of coagulase positive staphylococci (13 IgG was dialyzed against 0.1 M sodium acetate buffer, pH 4.5, and after dialysis, IgG (200 mg in 7.6 ml buffer) was treated with 2 mg crystallized pepsin (Nutritional Biochemical Co., Cleveland, Ohio). After 20 h at 37°C, the pH ofthe incubation mixture was adjusted to 8.0 with 1 N NaOH, and 25% Na2SO4 (wt/vol) was added dropwise, with stirring, to a final concentration of 0.18 g/ml (22 (25) and, after centrifugation, the platelet layer was filtered through a Sepharose 2B column (Pharmacia Fine Chemicals) equilibrated with Tyrode buffer, pH 7.4. The peak fractions were collected, sampled for platelet count and radioactivity counts, and the gel-filtered platelets used immediately in the experimental system in a concentration of 2 x 108/ml. Aggregation ofhuman platelets. Aggregation studies were done according to the method of Born (26) using a Payton Dual Channel Aggregometer (Payton Assoc., Buffalo, N. Y.). The aggregometer base line (10%) was set using platelet-rich plasma with staphylococci and buffer added in a concentration equivalent to the test system. Full transmission (100%) was set using an aggregated sample without stirring.
Platelets suspended in whole plasma were challenged with staphylococci using calculated concentrations of bacteria and with isolated protein A in concentrations determined by quantitation on an IgG immunodiffusion plate (27, 28) . When platelets separated from plasma proteins were used, the aggregometer was adjusted in a manner similar to that described for platelets in plasma. Aggregation was measured using percenlt maximum transmission and slope (29) which represented the change along a tangent line to the sharpest increase in light transmission.
Release of [3H]serotonin from platelets. Platelets suspended in whole plasma and labeled with [3H]serotonin were incubated at 37°C with staphylococci and with isolated protein A at different concentrations for 10 min with stirring. Samples were taken for total radioactivity counts, the incubation mixture centrifuged at 18,000 g for 2 min, and the supernates assayed for released radioactivity. Platelets, labeled with [3H]serotonin and separated from plasma proteins, were incubated as described above. Imipramine (Ciba-Geigy Corp., Summit, N. J.), at a concentration of 0.15 jug/ml, was used in all release reaction experiments.
Experiments with complement depleted plasma. Samples of plasma obtained from human blood anticoagulated withBinding of '251-protein A to platelets. Purified protein A vas labeled with 125I (Amersham Corp.) using the chloramine T method (31) . Platelets separated from plasma proteins were incubated at 37°C with 1251-protein A at concentrations from 1 to 10 ,ug/ml in the absence and presence of IgG and F(ab)2 fragment ofIgG, which were used in concentrations of 1 mg/ml and 0.6 mg/ml, respectively. At the end of the 10-min incubation, 40 mM EGTA was added to the incubation mixture, and it was poured into a filtration manifold (Millipore Corp., Bedford, Mass.) using 1-pm nucleopore filters (Arthur H. Thomas Co., Philadelphia, Pa.) which had been presoaked in 0.5% albumin. The samples were filtered under atmospheric pressure and then washed with 20 ml Tyrode buffer, pH 7.4, using a vacuum. The filters were removed and radioactivity associated with platelets was determined in a Searle Gamma Counter (Searle Radiographics, Inc., Des Plaines, Ill.).
Electron microscopy. Electron microscope observations were made on platelets suspended in whole plasma after challenge by staphylococci. After incubation, the samples were mixed thoroughly with an equal volume of2% glutaraldehyde in phosphate buffer, pH 7.3, and centrifuged at 18,000 g for 2 min. The pellets were again incubated in 2% glutaraldehyde for 2-3 h and then centrifuged. After secondary fixation in 1% Millonig's phosphate-buffered OSO4 (32) When staphylococci were treated with trypsin to remove protein A from their cell wall (see Methods) and substituted into the same system in a ratio of 2.5 staphylococci per platelet, their ability to induce platelet aggregation was abolished (tracing C), and release of serotonin was reduced to 38+12%. The dependence of human platelet aggregation by staphylococci on protein A was documented further by a blocking experiment in which free, isolated protein A in the concentration of 50 ,ug/ml completely prevented platelet aggregation by protein A-bearing staphylococci (results not shown). Electron microscopy of platelets challenged with protein A-bearing staphylococci showed large aggregates of platelets in which staphylococci were embedded. Platelets were almost totally degranulated and showed complex interdigitations with each other and were intimately associated with staphylococci.
Comparison of the effect of protein A-bearing staphylococci and protein A isolated therefrom on aggregation and release reaction of human platelets in whole plasma. The experimental model of staphylococci-induced human platelet injury used in this study enabled us to compare the effect of protein A bound to the staphylococcal cell wall (solid phase) with the effect of protein A isolated in a free, soluble form (fluid phase). Both forms of protein A, i.e., cell-bound and free, were added to platelet-rich plasma; and they demonstrated different patterns of interaction with human platelets. In the solid phase system, protein A induced both aggregation of platelets and release of serotonin. Both changes were dependent on the concentration of staphylococci (Table I) . By (Fig. 2) . Platelet aggregation was abolished in this system and release of [3H]serotonin was reduced almost twofold with 30 Zg/ml of isolated Fc fragment.
Subsequent experiments were performed to establish the role of the Fc fragment in the formation of a complex among protein A, IgG, and human platelets. Isolated protein A labeled with 125I and human platelets separated from plasma proteins were used. 1251-Protein A was not bound to platelets separated from plasma proteins unless IgG was added to the system (Fig. 3) . This The role of the complement system in the interaction between protein A and human platelets. The interaction of protein A with IgG is known to cause fixation of complement (35) . Therefore, we examined the possibility that the effect of protein A-bearing staphylococci on human platelets involves the complement system. Staphylococci with cell wall-bound protein A were preincubated in plasma anticoagulated with 1 U/ml heparin to allow binding of plasma proteins. After subsequent washing, opsonized staphylococci were added to human platelets separated from plasma proteins. A ratio oftwo staphylococci per platelet was used. Staphylococci exposed to intact, heparinized plasma induced normal platelet aggregation; and release of [3H] Protein A binds IgG through its Fc fragment with an average of-80,000 molecules/staphylococcus (36) , thus playing the role of a bacterial Fc receptor. The dependence of the interaction of staphylococci with human platelets on protein A is apparent from the experiments in which Protein A was stripped from the cell wall by trypsin treatment. Because the mucopeptide (murein) of the staphylococcal cell wall and teichoic acids are not substrates for trypsin (37, 38) , this experiment provided additional evidence that these basic structural units, which are the main anitigenic determinants of the staphylococcal cell wall, are not responsible for aggregation of human platelets in our system. Several lines of evidence indicate the existence of a human platelet receptor for the Fc fragment of IgG (39) (40) (41) , and recently an Fc fragmient-binding glvcoprotein has been isolated from hui-nan platelets by affinity chromatography (42 (39) (40) (41) . Neither aggregation nor release of serotonin occurred in whole plasma at physiologic platelet levels, although some binding of aggregated IgG to human platelets was observed (43) . Isolated, soluble protein A added to whole plasma in suboptimal, optimal, and supraoptimal concentrations could not induce measurable platelet aggregation, and only release of [3H]serotonin, somewhat reduced, was observed (Table I ). Therefore, free protein A in the fluid phase forms a complex with IgG that behaves differently (lack of platelet-aggregating activity) than the complex formed between IgG and cell wall-bound protein A in the solid phase system (full plateletaggregating activity).
Although the complement system was important for the functional effect of protein A in the rabbit platelet model (28) , in the case of the human platelets studied here, complement appears to be nonessential either for binding of 125I-protein A-IgG complexes to human platelets or for their aggregation and release reaction. Fixation of complement by protein A-IgG complexes is reduced when an equimolar ratio of protein A to IgG is attained (44) . It is possible that in our solid phase system, fixation of complement could occur; however, it did not depress or promote the interaction of staphylococci with human platelets.
It is apparent from our experiments that IgG binds simultaneously through its (45) . Thus, the unique interaction of the IgG molecule with two phylogenetically different Fc fragment receptors, one on the bacterial cell wall and t1ib other on the human platelet membrane, results in the formation of a tertiary complex. This can contribute to thromboembolic complications at the site(s) of intravascular staphylococcal infections.
